In today's world, health care is becoming increasingly personalized
If fatigue emerges, reducing your dose slightly for one or two weeks, then advancing more slowly, usually resolves the symptom while preserving weight loss momentum
HepG2 cell spheroids are more sensitive to hepatotoxic substances
Intrapatient changes in CT-based body composition after initiation of semaglutide (glucagon-like peptide-1 agonist) therapy
Impact of medication on protein and amino acid metabolism in the elderly: the sulfur amino acid and paracetamol case
Los agonistas del receptor GLP-1, una clase de medicamentos desarrollados originalmente para el tratamiento de la diabetes tipo 2 y hoy ampliamente utilizados en el manejo de la obesidad, estn transformando no slo la prctica clnica, sino tambin la conversacin econmica global